After publishing new HCV Birth Cohort 1945–1965 Screening Guidelines in 2012, CDC assessed a number of efforts at communication across the public and private sectors to enhance guideline uptake. At the national level, it was determined that the most effective approach would be individual sector implementation panels. Panels included formal presentations on the rationale for the guidelines, special presentations by invited guest speakers and suggestions on how each organization can support the implementation of the guidelines. Six panels have been conducted to date.
On January 11, 2013, VHAC, CDC, the American Association for the Study of Liver Diseases (AASLD) and the Infectious Diseases Society of America (IDSA) co-convened a panel discussion in Atlanta to obtain input from medical provider organizations. The meeting was attended by over 60 participants representing 23 healthcare provider organizations, including those focused on primary care, specialty care, and specific ethnic populations. Meeting dialogue and feedback were productive in support of helping facilitate implementation of the new testing recommendation. Several professional organizations issued an official endorsement of the guidelines after the panel.
The payer implementation panel was held on March 8, 2013 in Washington. Again, the panel was co-convened by the VHAC, CDC’s DVH, AASLD, and IDSA. Participants included health plans, advocacy groups, and several federal agencies. Payers expressed the need for Healthcare Effectiveness Data and Information Set (HEDIS) or National Committee for Quality Assurance (NCQA) measures and buy-in by large employers, as well as the importance of having independent government treatment guidelines similar to HIV.
A state forum was held in Oakland, CA, on November 8, 2013. The meeting was co-convened by the California Department of Public Health (CDPH), CDPH’s Viral Hepatitis Clinical Task Force, CDC’s DVH, VHAC, IDSA, and AASLD. The forum focused on HCV screening and clinical management in primary care and other health-care settings. The outcome of the forum included recommendations in California focused on policy and provider education and clinic-level tools and strategies, in addition to addressing pharmacy-based, laboratory-based, public education and surveillance approaches.
Stakeholder panels were held in 2015 in Florida, Massachusetts and Pennsylvania to advance the adoption and implementation of the hepatitis C (HCV) birth cohort testing guidelines. The meetings were led by each state’s health department and a diverse group of stakeholders from public health, health systems, government, academia and industry were invited to discuss the issues and opportunities in the hepatitis space within each state.
All of these panels were funded by AbbVie.